TARS   $52.6  -4.78% Market Closed After Close 53.0 0.76%

Tarsus Pharmaceuticals Inc
Total Cash 323.58M
totalCashPerShare 8.506
EBITDA -155.27M
Total Debt 73.63M
quickRatio 6.872
currentRatio 7.031
Total Revenue 83.37M
debtToEquity 29.191
Revenue/Share 2.434
ROA -0.34548
ROE -0.7504
grossProfits
freeCashflow -78.28M
operatingCashflow -123.89M
earningsGrowth
revenueGrowth
grossMargins 0.32778
ebitdaMargins -1.86234
operatingMargins -0.81597
profitMargins -1.7999699
enterpriseValue 1.49B
forwardPE -21.666666
floatShares 28.83M
sharesOutstanding 38.04M
sharesShort 9.68M
sharesShortPriorMonth 9.49M
dateShortInterest
sharesPercentSharesOut 0.25%
heldPercentInsiders 0.09%
heldPercentInstitutions 1.14%
Short Ratio help_outline 17.98%
shortPercentOfFloat 0.26%
impliedSharesOutstanding
bookValue 6.633
Price To Book help_outline 7.06
earningsQuarterlyGrowth
netIncomeToCommon -150.07M
trailingEps -4.46%
forwardEps -2.16%
enterpriseToEbitda -9.58
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.94 3Q 2024
institutionsCount 214
lastUpdated Nov. 7, 2024, 3:27 a.m.